Hepatocellular Carcinoma: Pharmacologic Management
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancer worldwide, accounting for approximately 75% of liver cancer diagnoses.
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancer worldwide, accounting for approximately 75% of liver cancer diagnoses.
Hodgkin lymphoma (formerly known as Hodgkin’s disease) is a rare type of lymphoma that accounts for only 0.5% of all new cancer cases in the United States.
Melanoma is a cancer that affects the melanocytes located in the skin (cutaneous) and neural crest cells located in the uveal tract of the eyes.
Malignant mesothelioma is a rare cancer that arises from mesothelial cells; it occurs most commonly in the pleura and peritoneum but is also known to cause primary tumors in the testes and heart.
Breast cancer is the most common type of cancer, with an estimated 300,590 new cases in the United States in 2023. The National Cancer Institute also estimates that breast cancer will account for 43,170 to 43,530 new deaths in 2023.
Multiple myeloma is a malignancy of the plasma cells. Multiple myeloma develops when clonal plasma cells proliferate in the bone marrow or form extramedullary plasmacytomas.
Myelodysplastic syndrome (MDS) represents a group of conditions that result from blood-forming stem cells in the bone marrow failing to mature properly into healthy blood cells.
Non-Hodgkin lymphoma (NHL) consists of a diverse group of lymphomas that originate in the lymphoid tissues and spread throughout the body.
Lung cancer is the second most common cancer in the United States and estimated to account for 12.2% of new cancer cases in 2023.
Among gynecologic cancers, ovarian cancer is associated with the most deaths and is the fifth most frequent cause of death overall in women.